Target intelligence / Profile preview

RN7SK pseudogene 231 (RN7SKP231)

Target
RN7SKP231
Molecular classification
Other (Pseudogene), Not a receptor, enzyme, transporter, or transcription factor
01

Overview

RN7SK pseudogene 231 (RN7SKP231) is a non-coding pseudogene related to the 7SK small nuclear RNA (RN7SK), a well-studied RNA involved in the regulation of RNA polymerase II transcription elongation through sequestration of the positive transcription elongation factor b (P-TEFb)[3][1][2]. RN7SKP231 itself does not produce functional RNA or protein; it is an inactive segment within the genome, believed to have arisen from duplication or retrotransposition events. There is no evidence suggesting RN7SKP231 has a role as a therapeutic target, nor does it have established biological or disease relevance. Clarification: - The entry “RN7SK pseudogene 231” is not a functional gene, protein, nor a direct therapeutic target. All molecular, functional, and disease associations described in the literature pertain to the functional RN7SK snRNA—not the pseudogene[2][1][3]. If you are interested in the functional RN7SK snRNA, it is a bona fide regulator of transcription elongation and cell differentiation and is linked to diseases when dysregulated, but this does not extend to pseudogenes. Summary of Core Points: - RN7SKP231 is a pseudogene. - It is not a therapeutic target or functional molecule. - No drugs, mechanisms, functions, or disease roles are attributed to it. - The actual 7SK RNA is a non-coding RNA involved in regulation of transcription, but RN7SKP231 is not active in these processes.

Other names
RN7SKP231RNA, 7SK small nuclear pseudogene 231
02

Mechanism of action

Not applicable

03

Biological functions

No known biological function (pseudogene)
04

Disease associations

None established (pseudogenes, in general, may sometimes be linked to regulation, but there is no specific evidence for RN7SKP231)

Beyond the preview

Go deeper on RN7SK pseudogene 231 (RN7SKP231).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RN7SK pseudogene 231 (RN7SKP231).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call